GlassScriptPhysician profile
Melissa Miranda
NPI 1235648882
$15,271.20
in general payments reported to CMS, 2019-2025
58 companies · $2,462 in 2025
The $2,462 reported for 2025 was more than what 95% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,986 · 2022: $3,807 · 2023: $3,768 · 2024: $3,248 · 2025: $2,462.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,477.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,068.05 | 2021-2025 | |
| Ucb, INC. | $1,534.13 | 2021-2025 | Briviact, Nayzilam, Fintepla |
| Pfizer INC. | $986.48 | 2023-2025 | |
| Neurocrine Biosciences, INC. | $761.99 | 2021-2025 | Ingrezza, Ongentys |
| Teva Pharmaceuticals USA, INC. | $691.25 | 2021-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Amgen INC. | $667.96 | 2021-2024 | Aimovig |
| Biohaven Pharmaceutical Holding Company LTD. | $584.14 | 2022 | |
| Lundbeck LLC | $531.35 | 2021-2025 | Vyepti, Rexulti |
| Lilly USA, LLC | $385.30 | 2021-2025 | Emgality, Amyvid, Kisunla |
| Jazz Pharmaceuticals INC. | $372.12 | 2021-2025 | |
| Upsher-Smith Laboratories LLC | $358.51 | 2021-2023 | |
| Sk Life Science, INC. | $303.44 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $300.95 | 2021-2025 | |
| Amneal Pharmaceuticals LLC | $280.98 | 2021-2025 | Rytary, Crexont, Brekiya |
| Eisai INC. | $277.53 | 2022-2025 |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mdd US Operations, LLC | $269.07 | 2022-2023 | Gocovri |
| Impel Pharmaceuticals INC. | $260.42 | 2022-2023 | Trudhesa |
| Otsuka America Pharmaceutical, INC. | $239.89 | 2023-2024 | Nuedexta, Rexulti |
| Biohaven Pharmaceuticals, INC. | $224.69 | 2021 | |
| Acadia Pharmaceuticals INC | $176.03 | 2024-2025 | Nuplazid, Daybue |
| Sumitomo Pharma America, INC. | $165.22 | 2023-2024 | Aptiom |
| Avanir Pharmaceuticals, INC. | $163.77 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $153.94 | 2022-2024 | Hyqvia |
| Catalyst Pharmaceuticals, INC. | $140.69 | 2023-2024 | Fycompa |
| Scilex Pharmaceuticals INC. | $138.82 | 2023-2024 | Ztlido |
| Seagen INC. | $124.99 | 2023 | Tukysa |
| Boston Scientific Corporation | $119.06 | 2025 | Wavewriter Alpha Prime 16, Lux-Dx Insertable Cardiac Monitor, Watchman Flx |
| Csl Behring | $115.26 | 2022-2024 | Hizentra |
| Kyowa Kirin, INC. | $110.45 | 2022-2023 | Nourianz |
| Allergan, INC. | $110.25 | 2021-2022 | |
| Acorda Therapeutics, INC | $107.99 | 2022-2024 | Inbrija |
| Argenx US, INC. | $102.17 | 2024-2025 | Vyvgart Hytrulo, Vyvgart |
| Biogen, INC. | $101.41 | 2021 | |
| Axsome Therapeutics, INC. | $100.54 | 2025 | Symbravo |
| Intuitive Surgical, INC. | $97.56 | 2024 | |
| Alexion Pharmaceuticals, INC. | $96.79 | 2022-2024 | Ultomiris |
| Celgene Corporation | $88.97 | 2024 | Zeposia |
| Neurelis, INC. | $87.93 | 2021-2024 | Valtoco |
| Janssen Biotech, INC. | $85.65 | 2022-2025 | |
| Sunovion Pharmaceuticals INC. | $83.10 | 2021-2022 | |
| Averitas Pharma INC. | $80.03 | 2025 | Qutenza |
| Horizon Therapeutics Plc | $59.07 | 2021 | |
| Mallinckrodt Hospital Products INC. | $55.13 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $54.28 | 2021-2022 | |
| Impel Pharmaceuticals LLC | $49.01 | 2025 | Trudhesa |
| Aucta Pharmaceuticals, INC. | $46.13 | 2025 | Motpoly Xr |
| Harmony Biosciences LLC | $42.72 | 2025 | |
| Arbor Pharmaceuticals, INC. | $41.12 | 2021 | |
| Genzyme Corporation | $39.81 | 2021-2022 | |
| Merz Pharmaceuticals, LLC | $37.91 | 2022-2024 | Xeomin |
| Supernus Pharmaceuticals, INC. | $36.15 | 2021-2022 | |
| Tanabe Pharma America, INC. | $34.81 | 2025 | Radicava |
| Currax Pharmaceuticals LLC | $28.12 | 2021-2023 | Onzetra Xsail |
| Almatica Pharma LLC | $25.43 | 2021 | |
| Avadel Cns Pharmaceuticals, LLC | $20.95 | 2024 | Lumryz |
| Banner Life Sciences, LLC | $20.33 | 2022 | |
| Collegium Pharmaceutical, INC. | $16.32 | 2022 | |
| Avion Pharmaceuticals | $15.04 | 2023 | Dhivy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Miranda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.